Selank – Lyophilized Powder
Selank is a synthetic peptide analog derived from tuftsin, widely studied for its role in neuroregulation, anxiolytic signaling pathways, and immune-neurological interactions. It is associated with mechanisms involving neurotransmitter modulation, neuropeptide balance, and central nervous system regulation under experimental conditions.
Commonly explored in advanced biochemical and neurological research models, Selank is investigated for its influence on GABAergic signaling, stress-response pathways, and cognitive function mechanisms. Research also examines its role in neuroinflammation modulation, immune signaling interactions, and maintenance of neurological stability.
Key Research Mechanisms
- Neuroregulatory Activity: Studied for its role in modulating GABAergic and serotonergic signaling pathways involved in stress-response and neurological balance.
- Cognitive Signaling Support: Investigated for its involvement in memory, learning pathways, and neurotransmitter regulation under experimental conditions.
- Immune-Neurological Interactions: Explored for its effects on cytokine balance, neuroinflammatory pathways, and maintenance of neuronal stability in research models.
Technical Specifications
| Common Name | Selank |
| Form | Lyophilized Powder (Freeze-Dried) |
| Receptor Targets | GABAergic, serotonergic, and immune-related signaling pathways |
| Biological Role | Synthetic peptide studied for neuroregulatory activity, cognitive signaling, and immune-neurological research mechanisms |
| Purity | ≥ 99% (HPLC) |
| Storage | Store at -20°C for long-term stability. Reconstituted solutions should be stored at 2–8°C and used promptly. Protect from light and moisture. |
⚠️ DISCLAIMER: FOR RESEARCH PURPOSES ONLY
This product is strictly intended for in-vitro laboratory research and development use only. Selank is not approved for human or animal consumption, therapeutic applications, or diagnostic use. Must be handled by qualified research professionals.






Reviews
There are no reviews yet.